All News

Adverse event reporting rules for dietary supplements effective Dec. 22.

PPA helps California fire victims access prescription medicines.

FDA announces public workshop on OTC drug use among adolescents.

New Jersey law requires pharmacists to dispense all medications, including birth control and emergency contraception.

FDA names 15 members for its new Risk Communication Advisory Committee.

Eight pharmacies chosen as Letairis distributors

U.S. Marshals seize more than $300,000 worth of drugs and dietary supplements

NACDS applauds Dextromethorphan Abuse Reduction Act of 2007

NACDS ranks as one of top places to work among associations and nonprofits.

The National Council for Prescription Drug Programs updated its HCIdea on-line database to include NPI numbers.

Home hygience can help tame MRSA, according to health care providers.

Roger Williams, CEO of United States Pharmacopeia, believes that our systems to prevent contaminated drugs from slipping into our country are not strong enough.

Pharmacists should own up to the job of medication reconciliation since they are the most knowledgeable of all health professionals on this subject.

New drugs, generics, dosages and indications

Participants at a recent roundtable meeting, including government and industry representatives, agreed to move forward with creating a forum on standardizing prescription medication labels.

Pharmacists must learn how to ensure their own safety with pharmacies a common target for theft.

Three pharmacists are the proud recipients of Eisai's hhc (human health care) Pharmacist Recognition Award.

The Pharmacist Services Technical Advisory Coalition has received approval for permanent mediation therapy management service CPT codes.

Pharmacists worked tirelessly to help patients during the influenza pandemic that killed more than 600,000 Americans in 1918.

At its annual convention the Nation Community Pharmacy Association pushes for greater political influence, medication therapy management, and new business models.

Azor (amlodipine/olmesartan medoxomil, Daiichi Sankyo) was recently approved by the FDA as a once-daily, oral tablet containing both a calcium channel blocker and an angiotensin receptor blocker.

Aspirin is one treatment that can be used with patients with deep vein thrombosis.

Pharmacists rally to help fire evacuees of the San Diego wildfires.

FDA advisory panel says OTC cough and cold meds should not be used by children under six.

Diclofenac gel approved for osteoarthritis

FDA approves new form of sevelamer for chronic kidney disease

Exubera (inhaled insulin) discontinued

AACP doesn't think pharmacists need to complete a residency before they can provide direct patient car